Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Tau phosphorylation in Alzheimer's disease: pathogen or protector?

Lee HG, Perry G, Moreira PI, Garrett MR, Liu Q, Zhu X, Takeda A, Nunomura A, Smith MA.

Trends Mol Med. 2005 Apr;11(4):164-9. Review.

PMID:
15823754
2.

A novel perspective on tau in Alzheimer's disease.

Bonda DJ, Castellani RJ, Zhu X, Nunomura A, Lee HG, Perry G, Smith MA.

Curr Alzheimer Res. 2011 Sep;8(6):639-42. Review.

PMID:
21605042
3.

Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.

Pei JJ, Sjögren M, Winblad B.

Curr Opin Psychiatry. 2008 Nov;21(6):555-61. doi: 10.1097/YCO.0b013e328314b78b. Review.

PMID:
18852562
4.

The role of tau phosphorylation in the pathogenesis of Alzheimer's disease.

Mi K, Johnson GV.

Curr Alzheimer Res. 2006 Dec;3(5):449-63. Review.

PMID:
17168644
5.

Neurofibrillary tangles and Alzheimer's disease.

Brion JP.

Eur Neurol. 1998 Oct;40(3):130-40. Review.

PMID:
9748670
6.

The role of neurofibrillary tangles in Alzheimer disease.

Brion JP.

Acta Neurol Belg. 1998 Jun;98(2):165-74. Review.

PMID:
9686275
7.

Alzheimer's disease: Abeta, tau and synaptic dysfunction.

LaFerla FM, Oddo S.

Trends Mol Med. 2005 Apr;11(4):170-6. Review.

PMID:
15823755
8.

Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications.

Deutsch SI, Rosse RB, Lakshman RM.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec 30;30(8):1369-80. Epub 2006 Jun 21. Review.

PMID:
16793187
9.

It may take inflammation, phosphorylation and ubiquitination to 'tangle' in Alzheimer's disease.

Arnaud L, Robakis NK, Figueiredo-Pereira ME.

Neurodegener Dis. 2006;3(6):313-9. Epub 2006 Sep 4. Review.

PMID:
16954650
10.

Tau phosphorylation in neuronal cell function and dysfunction.

Johnson GV, Stoothoff WH.

J Cell Sci. 2004 Nov 15;117(Pt 24):5721-9. Review.

11.

Probable participation of 14-3-3 in tau protein oligomerization and aggregation.

Sluchanko NN, Gusev NB.

J Alzheimers Dis. 2011;27(3):467-76. doi: 10.3233/JAD-2011-110692. Review.

PMID:
21876254
12.

Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain.

Smith MA, Casadesus G, Joseph JA, Perry G.

Free Radic Biol Med. 2002 Nov 1;33(9):1194-9. Review.

PMID:
12398927
13.

Tau and tauopathies.

Robert M, Mathuranath PS.

Neurol India. 2007 Jan-Mar;55(1):11-6. Review.

14.

Apolipoprotein E gene and Alzheimer's disease: is tau the link?

Lovestone S, Anderton B, Betts J, Dayanandan R, Gibb G, Ljungberg C, Pearce J.

Biochem Soc Symp. 2001;(67):111-20. Review.

PMID:
11447827
15.

From tau phosphorylation to tau aggregation: what about neuronal death?

Buée L, Troquier L, Burnouf S, Belarbi K, Van der Jeugd A, Ahmed T, Fernandez-Gomez F, Caillierez R, Grosjean ME, Begard S, Barbot B, Demeyer D, Obriot H, Brion I, Buée-Scherrer V, Maurage CA, Balschun D, D'hooge R, Hamdane M, Blum D, Sergeant N.

Biochem Soc Trans. 2010 Aug;38(4):967-72. doi: 10.1042/BST0380967. Review.

PMID:
20658986
16.

[Phosphorylation of tau and Alzheimer's disease].

García T, Jay D.

Gac Med Mex. 2004 May-Jun;140(3):329-33. Review. Spanish.

PMID:
15259345
17.

Phosphorylation of neuronal cytoskeletal proteins in Alzheimer's disease and Lewy body dementias.

Trojanowski JQ, Lee VM.

Ann N Y Acad Sci. 1994 Dec 15;747:92-109. Review. No abstract available.

PMID:
7847694
18.

Tau protein, the main component of paired helical filaments.

Avila J.

J Alzheimers Dis. 2006;9(3 Suppl):171-5. Review.

PMID:
16914856
19.

A second look into the oxidant mechanisms in Alzheimer's disease.

Moreira PI, Oliveira CR, Santos MS, Nunomura A, Honda K, Zhu X, Smith MA, Perry G.

Curr Neurovasc Res. 2005 Apr;2(2):179-84. Review.

PMID:
16181112
20.

Supplemental Content

Support Center